US Broker Ratings

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A High-Stakes Biotech with 43% Upside Potential

Praxis Precision Medicines, Inc. (PRAX) is gaining attention in the biotechnology sector, particularly among investors with a keen interest in companies developing breakthrough therapies for central nervous system (CNS) disorders...

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Navigating the Biotech Waters with a 48.8% Revenue Boost

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology industry with its innovative approach to addressing chronic endocrine and neurological diseases. Headquartered in Chicago, Illinois, the..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 20.5% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, is capturing investor attention with its noteworthy 20.5% revenue growth, despite facing a complex market landscape. Headquartered in..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: A Potential 56.69% Upside in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS) is making waves in the biotechnology sector with its promising portfolio of cancer therapies. As a clinical-stage biopharmaceutical company, Arcus is focused on developing and..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: A Potential 186% Upside on Promising Cancer Therapies

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology sector with a compelling growth narrative, particularly for investors seeking exposure to innovative cancer treatments. With a market capitalization of..

Zymeworks Inc. (ZYME) Stock Analysis: Biotechnology Innovator with a 27.9% Potential Upside

Zymeworks Inc. (NASDAQ: ZYME), a burgeoning player in the biotechnology sector, has caught the attention of investors with its promising therapeutic platforms and partnerships. With a market capitalization of $1.45..

CareDx, Inc. (CDNA) Stock Analysis: Uncovering a Potential 50.89% Upside in the Diagnostics Sector

As the healthcare landscape continues to evolve, CareDx, Inc. (NASDAQ: CDNA) stands out within the diagnostics and research industry. With a market capitalization of $770.19 million, the company is carving..

InMode Ltd. (INMD) Stock Analysis: Exploring the 13% Potential Upside in Medical Device Innovator

In the rapidly evolving healthcare sector, InMode Ltd. (NASDAQ: INMD) stands out as a noteworthy player in the medical devices industry. Headquartered in Yokne’am, Israel, InMode has been making significant..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unveiling a Potential 135% Upside in the Biotech Sector

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to developing small-molecule drugs targeting organ fibrosis. Headquartered..

Ardelyx, Inc. (ARDX) Stock Analysis: A 126% Potential Upside for Biotech Enthusiasts

Ardelyx, Inc. (NASDAQ: ARDX) is garnering attention in the biotechnology sector, with a notable potential upside of 126.82% based on current analyst ratings. This Waltham, Massachusetts-based company is focused on..

CureVac N.V. (CVAC) Stock Analysis: Riding the mRNA Wave Amidst Challenges

Investors eyeing the biotechnology sector are increasingly focusing on CureVac N.V. (NASDAQ: CVAC), a German biopharmaceutical company with a market cap of $1.21 billion. Known for its pioneering work in..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Potential Upside and Revenue Growth Drive Investor Interest

DoubleVerify Holdings, Inc. (NYSE: DV), a prominent player in the technology sector, offers a compelling opportunity for investors seeking exposure to digital media analytics. With a market capitalization of $1.86..

Diebold Nixdorf (DBD) Stock Analysis: Uncovering a 31.78% Potential Upside in the Tech Sector

Diebold Nixdorf Incorporated (NYSE: DBD), a stalwart in the technology sector, is catching the attention of investors with its significant potential upside of 31.78%. As a key player in the..

Cadence Design Systems, Inc. (CDNS) Stock Analysis: Unveiling a 10.79% Upside Potential

Cadence Design Systems, Inc. (NASDAQ: CDNS), a titan in the technology sector, is capturing the attention of investors with its software solutions for electronic design automation. With a market capitalization..

Paycom Software, Inc. (PAYC) Stock Analysis: Unveiling a 30% Potential Upside

Paycom Software, Inc. (NASDAQ: PAYC), a key player in the cloud-based human capital management (HCM) space, has captured the attention of investors with its robust business model and promising financial..

PAR Technology Corporation (PAR) Stock Analysis: Evaluating the 103% Upside Potential and Strategic Growth in the Tech Sector

PAR Technology Corporation (NYSE: PAR), a key player in the technology sector, is garnering significant attention from investors seeking growth opportunities within the software application industry. With a market capitalization..

Intapp, Inc. (INTA) Stock Analysis: Exploring a 58% Potential Upside in the AI-Powered Software Market

Intapp, Inc. (NASDAQ: INTA) stands at the confluence of technology and finance, offering AI-powered solutions to a range of industries. With a market capitalization of $3.16 billion, this Palo Alto-based..

RingCentral, Inc. (RNG) Stock Analysis: Exploring Growth Potential Amidst a 13% Upside

RingCentral, Inc. (NYSE: RNG), a prominent player in the cloud-based communications sector, offers a compelling opportunity for investors seeking exposure to the technology industry. With a market capitalization of $2.69..

Workday, Inc. (WDAY) Stock Analysis: A Deep-Dive into Its 21.94% Potential Upside

For investors eyeing the technology sector, Workday, Inc. (NASDAQ: WDAY) represents a compelling opportunity, particularly given its potential upside of 21.94% as indicated by its average target price. As a..

Uber Technologies, Inc. (UBER) Stock Analysis: Exploring a 13.70% Upside Potential and Robust Revenue Growth

Uber Technologies, Inc. (NYSE: UBER) continues to capture the attention of investors with its diverse technology-driven business model and promising growth metrics. As a leading player in the technology sector,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds